News & Events

For Immediate Release

No Credible Evidence to Support Cardiac Risk of Testosterone Therapy, Says Editorial in Journal of Men’s Health

New Rochelle, NY, May 5, 2014—Recent articles in the scientific literature and mass media that question the use of testosterone (T) therapy to treat T deficiency, or “low T,” and assert the cardiovascular risks of T therapy, are flawed, according to a provocative Guest Editorial in Journal of Men’s Health, a peer-reviewed publication from Mary Ann Liebert, Inc., publishers. The article is available on the Journal of Men’s Health website.

In “Testosterone Therapy and Cardiovascular Risk: A Cautionary Tale” Martin Miner, MD, The Warren Alpert School of Medicine, Brown University (Providence, RI), Joel Heidelbaugh, MD, University of Michigan Medical School (Ann Arbor), and Abraham Morgentaler, MD, Harvard Medical School (Boston, MA), state, “We object to comments that question the reality of T deficiency, regardless of whether it is called hypogonadism or, as in advertisements, ‘low T.’”

More data from larger, longer term studies are needed to assess potential effects of testosterone therapy on cardiovascular events in men. Based on the current evidence, the authors state, “we can find no foundation for suggesting new restrictions on T therapy in men with cardiac disease.”

About the JournalJournal of Men’s Health is the premier peer-reviewed journal published quarterly in print and online that covers all aspects of men’s health across the lifespan. The Journal publishes cutting-edge advances in a wide range of diseases and conditions, including diagnostic procedures, therapeutic management strategies, and innovative clinical research in gender-based biology to ensure optimal patient care. The Journal addresses disparities in health and life expectancy between men and women; increased risk factors such as smoking, alcohol abuse, and obesity; higher prevalence of diseases such as heart disease and cancer; and health care in underserved and minority populations. Journal of Men’s Health meets the critical imperative for improving the health of men around the globe and ensuring better patient outcomes. Tables of content and a sample issue can be viewed on the Journal of Men’s Health website.

About the PublisherMary Ann Liebert, Inc., publishers is a privately held, fully integrated media company known for establishing authoritative peer-reviewed journals in many promising areas of science and biomedical research, including Journal of Women’s Health, Journal of Endourology, Population Health Management, and LGBT Health, A complete list of the firm’s 80 journals, books, and newsmagazines is available on the Mary Ann Liebert, Inc., publishers website.